Bristol Myers: initiatives to advance health equity
The World Health Organization (WHO) defines SDoH as non-medical factors that influence health outcomes. These include: income and social status, education, physical environment, social support networks, genetics, health services and gender.
The new health equity grants build on the company's broader, long-term commitment to invest $150 million in health equity by 2025.
"These new health equity grants reinforce Bristol Myers Squibb's commitment to ensuring that all patients have access to high-quality healthcare, no matter where they live," commented Cari Gallman, executive vice president of corporate affairs at Bristol Myers Squibb.
Copyright (c) 2024 CercleFinance.com. All rights reserved.
Go to the original article.
Contact us to request a correction